Glycine Completed Phase 2 Trials for Schizophrenia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00268749Glycine Treatment of Prodromal Symptoms